Last reviewed · How we verify

NCT07161440: PCOSLCMS

Steroid Profiles in PCOS and Effect of OCP Treatment

Completed Last updated 8 September 2025
What this trial tests

trial in Polycystic Ovary Syndrome (PCOS) in 56 participants. Completed in 4 August 2025.

Timeline
2 January 2021
Primary endpoint
1 July 2024
4 August 2025

Quick facts

Lead sponsorIstanbul University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment56
Start date2 January 2021
Primary completion1 July 2024
Estimated completion4 August 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 13 to 21, female only, with Polycystic Ovary Syndrome (PCOS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational study investigates the changes in serum steroid intermediates assessed by liquid chromatography-mass spectrometry (LC-MS/MS) in adolescents and young women with polycystic ovary syndrome (PCOS), before and after oral contraceptive (OCP) treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome (PCOS)

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07161440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing